Lab Studies
20 Peptides Being Watched in Modern Research
This peptide library brings together 20 commonly discussed compounds across regeneration, neurobiology, metabolism, pigmentation, growth hormone signalling, mitochondrial biology, and obesity research. Each card gives a clean snapshot of the main research focus and links to a source readers can explore further.
BPC-157
BPC-157 is widely discussed in tendon, ligament, and soft-tissue repair research. Most of the published enthusiasm comes from animal and mechanistic literature rather than large modern human trials.
Research snapshot
- Often studied in tendon, muscle, and wound-healing models.
- Human evidence remains limited compared with online interest.
- Best framed as an experimental regenerative peptide rather than a clinically established therapy.
TB-500 (Thymosin Beta-4 Fragment)
TB-500 is generally discussed as a fragment-related derivative linked to the wider thymosin beta-4 literature. The strongest published evidence base sits with thymosin beta-4 biology in wound repair and angiogenesis rather than robust modern trials of commercial TB-500 use.
Research snapshot
- Commonly referenced for tissue repair and angiogenesis.
- Much of the evidence comes from animal and cell models.
- Useful to present as a research compound with incomplete translational evidence.
GHK-Cu
GHK-Cu is one of the better-known cosmetic and regenerative peptides, especially in skin-quality and hair-focused research. Compared with many niche peptides, it has a more established literature base in tissue repair and cosmetic science.
Research snapshot
- Frequently studied for collagen signalling and skin regeneration.
- Also appears in hair-growth and dermal delivery research.
- Typically positioned as a regenerative copper-complex peptide.
IGF-1 LR3
IGF-1 LR3 is often discussed in performance and tissue-growth settings, but its direct human evidence base is much thinner than the broader IGF-1 literature. Most discussion relies on extrapolation from IGF biology and preclinical work.
Research snapshot
- Connected to IGF-1 receptor signalling and anabolic pathways.
- Direct LR3-specific translational research remains limited.
- Best presented carefully, without overstating human outcomes.
Semax
Semax sits in the neuropeptide category and is commonly discussed in nootropic and neuroprotection circles. Recent published work continues to focus heavily on preclinical neurodegeneration and neural recovery models.
Research snapshot
- Often studied in cognition, neuroinflammation, and recovery pathways.
- Current literature still leans strongly preclinical.
- Relevant for a neuropeptide section, but not as a well-established mainstream therapy.
Selank
Selank is typically discussed for anxiolytic and neuroregulatory research. The literature includes mechanistic work, small clinical studies, and experimental models, but not the kind of large modern trial base seen with established psychiatric medicines.
Research snapshot
- Often positioned around anxiety-related and neurochemical pathways.
- Evidence includes molecular, animal, and smaller human studies.
- Credible to mention as an investigated neuroactive peptide, with restrained claims.
Dihexa
Dihexa is most often discussed in cognition and synaptogenesis research. It remains largely a preclinical compound, which makes it interesting scientifically but weakly established for real-world clinical translation at this stage.
Research snapshot
- Explored in memory and synaptic-connectivity models.
- Frequently referenced in Alzheimer’s-adjacent discussions.
- Evidence is mostly non-human and should be framed that way.
CJC-1295
CJC-1295 is a long-acting GHRH analog studied for sustained growth hormone and IGF-1 elevation. It has real human pharmacokinetic and pharmacodynamic data, which gives it a stronger published base than many performance-oriented peptides.
Research snapshot
- Studied for prolonged GH and IGF-1 elevation.
- Human studies exist in healthy adults.
- Relevant for endocrine and GH-axis content rather than generic “anti-aging” claims.
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue that appears in endocrine and body-composition discussions. Its published base includes human pharmacokinetic and growth-hormone–releasing studies, though it remains far from mainstream routine therapy.
Research snapshot
- Developed to stimulate GH release more selectively.
- Human PK/PD work is available.
- Best framed around endocrine signalling rather than sweeping physique claims.
Tesamorelin
Tesamorelin has one of the strongest human evidence bases on your list. It has been studied extensively in HIV-associated visceral adiposity and remains one of the clearer examples of a peptide with established clinical relevance.
Research snapshot
- Best known for visceral fat and metabolic-body-composition research.
- Supported by randomized human trial data and newer reviews.
- A much stronger evidence tier than most experimental peptides listed here.
Hexarelin
Hexarelin is an older synthetic growth hormone secretagogue with published human GH-release studies. It remains relevant historically in the secretagogue literature, even though it is less central in current mainstream peptide discussion than GLP-1–based therapies.
Research snapshot
- Studied for dose-dependent growth hormone release.
- Published human studies exist, but much of the literature is older.
- Useful for hormone-axis context and secretagogue comparison.
AOD-9604
AOD-9604 is a fragment derived from the C-terminus of growth hormone and is usually discussed in fat-loss research. The published literature is more modest than many marketing claims suggest, but there are clinical safety summaries and obesity-focused discussions.
Research snapshot
- Usually positioned around body-fat and metabolic research.
- Clinical literature often emphasizes safety and tolerability.
- Should be described cautiously rather than as a proven fat-loss solution.
Melanotan II (MT-2)
Melanotan II is mainly discussed for pigmentation and tanning effects. There is human evidence showing tanning activity, but it is also widely described as unlicensed and inadequately tested, so a neutral research framing is much safer and more credible.
Research snapshot
- Studied for melanocortin-driven pigmentation effects.
- Human tanning activity has been reported in older studies.
- Often presented with caution because formal modern evidence and regulatory status are limited.
Retatrutide
Retatrutide is one of the most closely watched next-generation obesity peptides because it targets GLP-1, GIP, and glucagon pathways together. It is still investigational, but the phase 2 obesity data made it one of the standout metabolic peptide stories in recent years.
Research snapshot
- Built around triple-hormone receptor agonism.
- Strong interest in obesity and metabolic disease research.
- Important to present as an investigational therapy rather than an approved product.
Semaglutide
Semaglutide is one of the strongest evidence-based peptides in modern metabolic medicine. Its literature spans obesity, cardiovascular outcomes, kidney disease, liver disease, and weight-related symptom improvement across multiple large human trials.
Research snapshot
- Major research focus in obesity and cardiometabolic disease.
- Supported by extensive large-scale human trial data.
- A cornerstone peptide for any serious metabolic-research library.
Epitalon (Epithalon)
Epitalon is commonly discussed in longevity circles because of its association with telomerase and aging-related laboratory research. The mechanistic interest is real, but the modern clinical evidence base is much less substantial than the marketing around it.
Research snapshot
- Often linked to telomere and aging-related cellular research.
- Most compelling evidence remains mechanistic or laboratory-based.
- Useful for longevity content, but best kept carefully phrased.
Thymalin
Thymalin is a thymus-derived peptide complex usually discussed in immune-regulation and aging-related research. The literature exists, but much of it is older, region-specific, or not equivalent to the contemporary trial standards used for major global therapeutics.
Research snapshot
- Typically associated with thymic and immune-system regulation.
- Published data exist, though the evidence style is uneven.
- Better suited to an exploratory peptide archive than to strong clinical claims.
MOTS-c
MOTS-c is a mitochondrial-derived peptide that has become a major topic in metabolism, exercise signalling, and healthy-aging research. Interest is high, but clinical translation still trails behind the volume of preclinical enthusiasm.
Research snapshot
- Usually studied in metabolic stress and mitochondrial signalling contexts.
- Frequently discussed in exercise and aging research.
- Still better described as an emerging mitochondrial peptide than a clinically established one.
Humanin
Humanin is another mitochondrial-derived peptide that appears often in neuroprotection, metabolic regulation, and cellular stress discussions. The research story is intriguing, but much of the work is still exploratory and mechanistic.
Research snapshot
- Frequently linked to cytoprotective and neuroprotective pathways.
- Part of the broader mitochondrial-derived peptide field.
- A useful peptide to feature in advanced longevity and mitochondrial content.
Tirzepatide
Tirzepatide is one of the dominant names in obesity and metabolic peptide research. Its large clinical-trial base makes it one of the clearest examples of a peptide with robust modern evidence across body weight, glycemic control, and related metabolic outcomes.
Research snapshot
- Widely studied in obesity and type 2 diabetes.
- Supported by landmark large-scale human trials.
- One of the strongest evidence-backed metabolic peptides available today.